Last updated on April 19, 2014 at 13:20 EDT

Latest Secretin receptor family Stories

2013-07-17 12:26:28

WELWYN GARDEN CITY, England and BOSTON, July 17, 2013 /PRNewswire/ -- Unique structural insights from CRF1 structure will drive drug discovery programmes targeting important Class B GPCRs including GLP1 (diabetes) Heptares Therapeutics, the leading GPCR drug discovery and development company, announces the publication of a scientific article describing the high resolution X-ray crystal structure of the corticotropin-releasing factor receptor 1 (CRF1)...